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ABSTRACT 
Introduction 
There are now nearly 50,000 children with a life-limiting or life-threatening conditions in the 
UK. These include conditions where there is no reasonable hope of cure and from which they 
will die, as well as conditions for which curative treatment may be feasible but can fail, e.g. 
cancer or heart failure. Having a child with a life-limiting condition involves being a 
coordinator and provider of healthcare in addition to the responsibilities and pressures of 
parenting a child who is expected to die young. This adversely affects the health and wellbeing 
of these mothers and affects their ability to care for their child, but the extent of the impact 
is poorly understood.  
This study aims to quantify the incidence and nature of mental and physical morbidity in 
mothers of children with a life-limiting condition, their healthcare use and to assess whether 
there is a relationship between the health of the mŽƚŚĞƌĂŶĚƚŚĞĐŚŝůĚ ?ƐĐŽŶĚŝƚŝŽŶ ? 
Methods and analysis 
A comparative cohort study using data from the Clinical Practice Research Datalink (CPRD) 
and linked hospital data will include three groups of children and their mothers (those with a 
life-limiting condition, those with a chronic conditions and those with no long term health 
condition total =20,000 mother-child dyads). Incidence rates and incidence rate ratios will be 
used to quantify and compare the outcomes between groups with multivariable regression 
modelling used ƚŽĂƐƐĞƐƐƚŚĞƌĞůĂƚŝŽŶƐŚŝƉďĞƚǁĞĞŶƚŚĞĐŚŝůĚ ?ƐĚŝƐĞĂƐĞƚƌĂũĞĐƚŽƌǇĂŶĚŵŽƚŚĞƌ ?Ɛ
health. 
Ethics and dissemination 
This study protocol has approval from the Independent Scientific Advisory Committee for the 
UK Medicines and Healthcare products Regulatory Agency Database Research. The results of 
this study will be reported according to the STROBE and RECORD guidelines. There will also 
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be a lay summary for parents which will be available to download from the Martin House 
Research Centre website (www.york.ac.uk/mhrc ).  
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ARTICLE SUMMARY 
Strengths and Limitations of this study 
This study is utilising a large, longitudinal, nationally representative primary care data source. 
The Clinical Practice Research Datalink data enables the identification of mother and child 
dyads and linkage to secondary care data. 
This study is reliant on identification of the cohort of interest by diagnostic coding therefore 
on the quality of diagnostic coding within the CPRD and HES datasets.  
 
INTRODUCTION 
The number of children with life-limiting or life-threatening conditions  has been rising, with 
latest figures estimating 49,000 children and young people with a life-limiting condition in the 
UK.1  These include conditions for which there is no reasonable hope of cure and from which 
children or young people will die, as well as conditions for which curative treatment may be 
feasible but can fail, such as cancer or heart failure. In children and young people, more than 
300 diagnoses are life-limiting or life-threatening2 , including duchenne muscular dystrophy, 
severe cerebral palsy, neurodegenerative conditions, and severe congenital anomalies. 
Although many of the individual diagnoses are rare, collectively life-limiting conditions affect 
more children and young people than more common single long term conditions, such as 
diabetes mellitus3 . Many of these children are living longer due to the use of medical 
technologies, e.g. ventilation and gastrostomy feeding, and more aggressive treatment of 
complications and they are often high users of healthcare services4 . The parents of these 
ĐŚŝůĚƌĞŶŚĂǀĞĂŶĂĚĚĞĚůĂǇĞƌŽĨ ?ƉƌĞƐƐƵƌĞ ?ĨƌŽŵŚĂǀŝŶŐĂĐŚŝůĚ with a chronic condition who 
also has a shortened life expectancy5 . Having a child with a life-limiting condition often 
involves being a coordinator and provider of healthcare as well as being a parent, and this 
responsibility exists 24 hours a day, 7 days a week, especially for mothers. The health of these 
mothers is important, both for their own well-being, and also in terms of their ability to care 
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for their child. Currently the National Health Service and statutory services for these children 
rarely extend to providing care for the parents. The focus is on mothers rather than fathers in 
this study as mothers are the main carer for the majority of these children.  
The need for further research on the emotional and psychological support and interventions 
for parents or carers of children with a life-limiting condition was highlighted recently in 
National Institute for Health and Clinical Excellence (NICE) guidelines on end of life care 
in children and young people6  ?dŚŝƐƐƚĂƚĞĚƚŚĂƚƌĞƐĞĂƌĐŚǁĂƐŶĞĞĚĞĚŽŶ  ?tŚĂƚĞŵŽƚŝŽŶĂů
support do children and young people with life-limiting conditions and their parents or carers 
need, and how would they like these needs to be addressed? The NICE guidelines6 also noted 
that no studies had quantified the psychological/ mental health of mothers of children with 
life-limiting condition. There have been some attempts to quantify these in children with 
special needs7 or specific disabilities8 9  which have shown higher levels of parental distress or 
emotional problems than parents of healthy children (36% cf 20%). These however, do not 
address the specific needs of those with life-limiting conditions or the added burden that 
parents of children with a life-limiting condition face, knowing their child is likely to die. 
Evidence about the physical health of mothers with life-limiting condition is also sparse, 
although two studies in mothers of children with disabilities found higher prevalence of 
physical conditions compared to mothers of healthy children. For example, prevalence of 
back pain and hypertension was 35.2% and 24.7% respectively in mothers of children with 
disabilities, compared to 26.7% and 19.1% in mothers of healthy children. However, these 
studies were cross sectional, self-reported and were not explicitly for mothers of children with 
a life-limiting condition 9 10. To date, no study using a nationally representative sample has 
assessed the incidence or prevalence of mental and physical health conditions in mothers of 
children with a life-limiting condition.  Quantifying the extent and nature of both physical and 
mental health conditions in these mothers is important when trying to develop and target 
appropriate preventative or treatment interventions for this population. 
This study aims to quantify the incidence and nature of mental and physical morbidity in 
mothers of children with a life-limiting condition, their healthcare use and to assess whether 
there is a relationship between the health of the mŽƚŚĞƌĂŶĚƚŚĞĐŚŝůĚ ?ƐĐŽŶĚŝƚŝŽŶ ? 
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METHODS AND ANALYSIS  
Research Questions 
1. What is the nature and incidence of mental and physical morbidity in mothers of 
children with a life-limiting condition? 
2. tŚĂƚŝƐƚŚĞƌĞůĂƚŝŽŶƐŚŝƉďĞƚǁĞĞŶƚŚĞŚĞĂůƚŚŽĨƚŚĞŵŽƚŚĞƌĂŶĚƚŚĞĐŚŝůĚ ?ƐĐŽŶĚŝƚŝŽŶ ?
3. How many primary care visits do these mothers have compared to other mothers? 
4. How many hospital admissions do these mothers have compared to other mothers? 
5. What are the resource costs of healthcare for these mothers? 
Data sources and sample selection 
This will be an observational comparative cohort study design using data from the Clinical 
Practice Research Datalink (CPRD). The CPRD dataset contains anonymized, longitudinal 
records of primary care from a representative sample of GP practices across the UK (covering 
approximately 8.5% of the UK population)11. Individuals within the primary care CPRD dataset 
are also linked to secondary care data (inpatient, outpatient, A & E Hospital Episodes Statistics 
(HES) and the Mental Health Minimum Dataset (MHMDS))12 13 and Office for National 
Statistics death certificate data. The CPRD provides a unique opportunity to assess the 
relationship between maternal morbidity and their child health due to the longitudinal nature 
of data collection (since 1987) and the ability to link mothers and children via their mother-
baby link algorithm14. It is not currently possible to link babies to fathers in this dataset. 
The index children will be extracted from the CPRD mother baby linkage, where the mother 
has at least 1 years registration and where they eligible for HES linkage (resident in England). 
Children will be grouped in to those with a life-limiting condition (n~5000) or chronic 
condition that is not life-limiting e.g. diabetes, asthma (n~5000) and they will be identified 
within the CPRD dataset between 2007-2017, using READ codes in the CPRD data and ICD10 
codes in the HES data1 (see Table 1) . The development of these ICD-10 code list have been 
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described previously for life-limiting1 and chronic conditions15. Subjects will be matched by 
year of birth, sex and region to the control group of healthy children (n~10,000) with no long 
term conditions.  
All primary and the linked secondary care data will be extracted for each mother and child 
dyad. 
Table 1 Cohort identification processes 
Groups Inclusion criteria Exclusion Criteria 
1. Life-limiting or life-
threatening condition 
x Children from the source 
population who have prevalent 
diagnosis event records for life-
limiting conditions, either in the 
Clinical or Referral files in CPRD 
GOLD based on the Read codes 
detailed in Supplementary 
material, or in HES APC based on 
the ICD-10 codes in 
Supplementary material.  
x Children have above events 
before the end of the study 
period (31/12/2017). 
x Children have above events 
within their UTS follow-up period. 
x Children are aged 18 years or less 
on the diagnosis event date. 
 
None 
2. Chronic condition that 
is not life-limiting 
One matching control will be provided 
for each case in Group 1. The controls 
will comprise of patients from the 
source population who fulfil the 
following criteria: 
x Children from the source 
population who have diagnosis 
event records for other chronic 
conditions in the Clinical or 
Referral files in CPRD GOLD based 
 ?ŚŝůĚƌĞŶ ǁŝƚŚ Ă ĚŝĂŐŶŽƐŝƐ
on or before 31/12/2017 of 
life-limiting conditions, 
either in the Clinical or 
Referral files in CPRD GOLD 
based on the Read codes 
detailed in Appendix 1, or in 
HES APC based on the ICD-
10 codes in Appendix 2. 
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on the Read codes detailed in 
Supplementary material, or in 
HES APC based on the ICD-10 
codes in Supplementary material. 
x Children have above events 
before the end of the study 
period of (31/12/2017). 
x Children have above events 
within their UTS follow-up period. 
x Children are aged 18 years or less 
on the diagnosis date. 
 
 ? Children who have 
deregistered from the CPRD 
on or before 01/04/2007 
 ? Children who are 
siblings of children in the 
case population (Group 1), 
based on having a link to the 
same mother in the Mother 
Baby Link 
3. No long term 
conditions 
Up to two matching controls will be 
provided for each case in Group 1. The 
controls will comprise of patients 
from the source population who fulfil 
the following criteria: 
x Children from the source 
population who have at least one 
day of registration during follow-
up start and end.  
 
x Children with a 
diagnosis of life-limiting 
conditions on or before 
31/12/2017, either in 
the Clinical or Referral 
files in CPRD GOLD 
based on the Read 
codes detailed in 
Appendix 1, or in HES 
APC based on the ICD-
10 codes in Appendix 2, 
will be excluded 
x Children with a 
diagnosis of other 
chronic conditions on 
or before 31/12/2017, 
in the Clinical or 
Referral files in CPRD 
GOLD based on the 
Read codes detailed in 
Appendix 3, or in HES 
APC based on the ICD-
10 codes in Appendix 4, 
will be excluded. 
x Children who have 
deregistered from the 
CPRD on or before 
01/04/2007 
x Children who are 
siblings of children in 
the case population 
(Group 1), based on 
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having a link to the 
same mother in the 
Mother Baby Link 
 
 
Sample size 
A sample size calculation based on 80% power, 5% significance to detect  
an incidence rate ratio of 1.4 (with mean incidence rate of 0.03 in maternal 
anxiety/depression) indicated a minimum of 3,260 participants required in each group. The 
final cohort includes all children with a life-limiting condition in the CPRD dataset. The cohort 
for analyses contained a total of 35,683 mothers, of whom 8,950 had a child with a life-limiting 
condition, 8,868 had a child with a chronic condition and 17,865 had a child with no long-term 
condition. 
 
Exposures 
The key exposure is the disease status of the child (life-limiting condition/chronic disease 
(asthma or diabetes)/ no long-term condition). These groups will be identified using 
previously developed READ and ICD 10 diagnostic code lists (see supplementary material). 
The use of both READ and ICD 10 codes will enable identification of relevant diagnoses from 
either the primary care records (READ) or hospital admission data (ICD 10).  
Outcomes 
The outcomes for the mothers will be recorded in either the primary care data or the linked 
secondary care datasets. The dates of these outcomes will be assessed in relation to the date 
of the ĐŚŝůĚ ?ƐĚŝĂŐŶŽƐĞƐ. 
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Incidence of mental health and physical health conditions 
¾ Maternal mental health diagnoses, including both common mental illness and severe 
mental illness. These will be identified using diagnostic READ codes and relevant 
prescription data. A previously developed READ code algorithm16 will be utilised. The 
linked MHMDS will indicate the presence of a more serious mental health conditions. 
¾ Maternal physical diagnoses, including e.g. obesity, hypertension, musculoskeletal 
problems, and cardiovascular disease. These will be identified using diagnostic READ 
codes, relevant prescription data, HES data, and related biometric data (including 
blood pressure, BMI, and total cholesterol). 
dŚĞĂƐƐŽĐŝĂƚŝŽŶŽĨŵĂƚĞƌŶĂůŚĞĂůƚŚǁŝƚŚƚŚĞĐŚŝůĚ ?ƐĚŝƐĞĂƐĞƚƌĂũĞĐƚŽƌǇ 
¾ The number of A&E attendances, hospital admissions and length of stay for the 
children (HES data). 
Healthcare use and resources of the mother 
¾ Referrals to other services, especially secondary services for mothers (CPRD and HES 
data). 
¾ Uptake of cervical screening by mothers (CPRD data). 
¾ The number of primary care attendances (GP, practice nurse etc.) per year by mothers 
(CPRD data) 
¾ The number and nature of prescribed medication for mothers (Prescription data). 
¾ The number of A&E attendances, hospital admissions and length of stay for mothers 
(HES data). 
Confounding 
The following clinical and demographic confounders will be considered in the analyses: 
¾ Ethnicity, this will be classified according to the census 2011 categories17 using data 
from CPRD and HES data. 
¾ Pre-existing comorbidities of the mother 
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¾ ŚŝůĚ ?ƐĚŝĂŐŶŽƐĞƐ: grouped into disease categories1  
¾ Socioeconomic data is based on the index of multiple deprivation category based on 
the local superoutput area of residence18  
 
¾ Region of residence (recognising that the geographical coverage of CPRD is not 
uniform across England). 
Statistical methods 
All analyses will be undertaken using STATA version 1519. All analyses will adjust for known 
clinical and demographic confounders of importance (age, co-morbidities, socioeconomic 
status, previous use of primary care services, etc.). The left and right censored nature of these 
data will be taken into account when undertaking these analyses. 
Incidence of mental health and physical health conditions 
Incidence rates of the physical and mental health conditions will be calculated in each group 
of mothers by dividing the number of cases in each group by the person-time at risk in each 
group. Incident cases will be counted only after the diagnoses in the child. A comparison with 
the incidence of these conditions in the three groups of mothers will be undertaken using 
incidence rate ratios. 
The association of maternal health ǁŝƚŚƚŚĞĐŚŝůĚ ?ƐĚŝƐĞĂƐĞƚƌĂũĞĐƚŽƌǇ 
The presence of physical or mental health diagnoses in the mother will be the outcome 
variable of interest in a multivariable model with a key covariate being the presence of 
prolonged or repeated hospital admission for the child. A prolonged admission is one that 
lasts > 14 days and repeated admissions will be defined as more than 2 admissions in a 6 
month time period. 
Healthcare use and resources of the mother 
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Using multivariable Poisson regression modelling for the count of GP visits, referrals and 
hospital admissions with the key exposure of disease status of the child (life-limiting condition 
/Chronic disease/ no long-term condition). Multilevel modelling will be used to account for 
repeated measures within individuals. For the analyses of healthcare costs, we will use 
information from Unit Costs of Health and Social Care20 , the NHS national tariffs21  and 
Department of Health Reference Costs22 . 
Missing data 
We expect there to be missing data for some of the key covariates in the data e.g. ethnicity. 
We will assess the level of missingness across all sources of these variable (HES and CPRD). If 
appropriate then we will use multiple imputation techniques 23 to address this in order to 
avoid the potential bias from only undertaking complete case analyses. 
PATIENT AND PUBLIC INVOLVEMENT 
The views of parents and carers of children with a life-limiting condition have informed the 
development of this study. Initial ideas about the topic area and planned study were discussed 
with a group of 10 parents of children with a life-ůŝŵŝƚŝŶŐĐŽŶĚŝƚŝŽŶĂƚDĂƌƚŝŶ,ŽƵƐĞŚŝůĚƌĞŶ ?Ɛ
Hospice. They helped to refine the research question and future stages of this programme of 
work. The Family Advisory Board of the Martin House Research Centre 
(www.york.ac.uk/mhrc) will have involvement in this study with an emphasis on the 
preparation of the lay summaries and dissemination to parents and children. 
ETHICS AND DISSEMINATION 
This study protocol has approval from the Independent Scientific Advisory Committee for the 
UK Medicines and Healthcare products Regulatory Agency Database Research (protocol 
18_313). They have NREC approval for release of pseudonymised data for observational 
research. 
This study will be complete by Feb 2021. 
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The results of this study will be reported according to the STROBE and RECORD guidelines 
(ref). There were also be a lay summary for parents which will be available to download from 
the Martin House Research Centre website (www.york.ac.uk/mhrc ). 
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